Healthcare Organizations Call for FDA Action on Compounding Regulations Amid GLP-1 Shortages
March 23, 2025 - 10:21
Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) have taken a significant step by sending a letter to the U.S. Food and Drug Administration (FDA). This letter, supported by over 20 prominent organizations and providers from various sectors of healthcare, emphasizes the urgent need for the FDA to implement and enforce federal regulations concerning compounding practices.
The call to action comes in the wake of recent shortages of GLP-1 medications, which are crucial for the treatment of obesity and related conditions. These shortages have raised serious concerns about patient access to essential therapies. The coalition argues that without stricter oversight and regulation of compounded medications, patients may face continued disruptions in their treatment options.
Healthcare leaders are advocating for a timely response from the FDA to ensure that patients receive the medications they need without interruption, highlighting the importance of regulatory frameworks in safeguarding public health.
MORE NEWS
June 13, 2026 - 16:13
Tracy residents worry about health risks after warehouse fireResidents in Tracy are voicing growing concerns about lingering smoke and potential toxic chemicals in the air following the massive fire at the Medline warehouse earlier this week. The blaze,...
June 12, 2026 - 17:15
These 20-Somethings Are Turning to Double Mastectomies | WSJ Health for June 12A growing number of women in their twenties are opting for double mastectomies, a trend that is reshaping conversations around breast cancer prevention and body autonomy. According to recent health...
June 12, 2026 - 06:34
Neurosurgeon Dr. Christopher Conner Honored as 2026 CHA Healthcare HeroA neurosurgeon whose innovative techniques are changing the landscape of recovery for patients with severe brain injuries has been named the 2026 CHA Healthcare Hero. Dr. Christopher Conner, a...
June 11, 2026 - 21:00
Leadership vacuum plaguing U.S. health agenciesA growing leadership vacuum is unsettling the country`s top public health institutions. The Centers for Disease Control and Prevention and the Food and Drug Administration have both seen a wave of...